First Tracks (TRAX) news

First Tracks Biotherapeutics shares rise 1% after $200 million equity raise

First Tracks Biotherapeutics (TRAX) shares rose approximately 1% following the company’s announcement of a $200 million private placement on October 15, 2026. The equity raise is intended to support the company’s ongoing clinical development programs, including its Phase 1b trial of ANB033, a CD122…

First Tracks Biotherapeutics shares rise 2.6% premarket after co announces $200 million private placement

First Tracks Biotherapeutics - Proceeds to be used for corporate purposes and clinical development of ANB033

First Tracks Biotherapeutics reports $20M placement

First Tracks Biotherapeutics - To sell 6,106,870 shares at $32.75 per share in private placement